a stack is four questions at once: whether anything in it fights anything else, whether you are paying twice for the same mechanism, what it costs, and where to buy it. this is a safety tool, not medical advice, and not a recommendation to combine anything.
built and named by sean; open one for safety, overlap, cost and where to buy it
61 stacks shown
these verdicts are class-level heuristics; this is NOT medical advice in any capacity. this is purely for human harm reduction and informative purposes. no dosing NOR safety protocols can be enforced. liver-enzyme (CYP450) flags only fire on the serious, well-documented metabolic interactions; minor pharmacokinetic bumps are left unflagged, and no flag is not proof of safety. interactions will heavily depend on baseline neurology, dose, timing, and context. talk to a qualified professional before combining any drugs with one another, and inform yourself.
add up to six compounds; the checker reads every pair before you mix.
six is the max for a clean read; remove one to swap.
checking Nefiracetam, TAK-653, Aniracetam, Tropisetron, PRL-8-53, and Bromantane: at least one combination is flagged to avoid (11 compatible pairs, 1 to watch, 1 to avoid). treat the red pairs as a reason to reconsider mixing.
Aniracetam plus a strong AMPA potentiator (TAK-653) piles on excitatory glutamate load too hard.
TAK-653 is a potent AMPA potentiator; adding a stimulant on top can over-drive glutamatergic tone.
noted as a compatible pairing in TAK-653's own profile; no adverse interaction flagged.
noted as a compatible pairing in Nefiracetam's own profile; no adverse interaction flagged.
carries no adverse class-level interaction with most compounds.
noted as a compatible pairing in PRL-8-53's own profile; no adverse interaction flagged.
Nefiracetam's cholinergic + GABAergic profile carries no adverse class-level interaction with a stimulant.
carries no adverse class-level interaction with most compounds.
Aniracetam carries no adverse class-level interaction with most cognitive compounds.
Aniracetam carries no adverse class-level interaction with most cognitive compounds.
Aniracetam carries no adverse class-level interaction with most cognitive compounds.
carries no adverse class-level interaction with most compounds.
Tropisetron's cholinergic / anti-inflammatory profile carries no adverse class-level interaction with a stimulant.
no notable interaction flagged; these look broadly independent.
no notable interaction flagged; these look broadly independent.
one pair to avoidavoid
all in one basketKimera Chems; Code Sean
5 of 6 priced
1 of these carry no listed price, so there is no honest total to print; the lines above are what can actually be costed.
3 overlapssame lever, twice